GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (BSP:ABBV34) » Definitions » Cash Receipts from Securities Related Activities

AbbVie (BSP:ABBV34) Cash Receipts from Securities Related Activities


View and export this data going back to 2016. Start your Free Trial

What is AbbVie Cash Receipts from Securities Related Activities?

Cash Receipts from Securities Related Activities only applicable to companies reporting Cash Flow from Operations in direct method.


AbbVie (BSP:ABBV34) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (BSP:ABBV34) » Definitions » Cash Receipts from Securities Related Activities
Address
1 North Waukegan Road, North Chicago, IL, USA, 60064-6400
AbbVie is a pharmaceutical firm with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.